GlassScriptPhysician profile
James M Sanders
NPI 1235398231
$4,045.05
in general payments reported to CMS, 2019-2025
15 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,634 · 2020: $818 · 2021: $48.90 · 2022: $93.15 · 2023: $120 · 2024: $114 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.51 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,178.97 | 2019-2024 | |
| Ethicon US, LLC | $276.49 | 2019-2023 | Enseal, Echelon Flex |
| Davol INC. | $178.87 | 2020-2025 | Phasix Mesh |
| Abbvie INC. | $69.04 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Endogastric Solutions, INC | $64.54 | 2024 | Esophyx |
| Allergan, INC. | $49.33 | 2020-2022 | |
| Kerecis Limited | $29.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Atricure, INC. | $25.19 | 2022 | |
| Merck Sharp & Dohme LLC | $21.54 | 2022 | |
| Integra Lifesciences Corporation | $20.06 | 2023 | Biodrestore, Medihoney, Biofix |
| Dilon Technologies, INC. | $17.62 | 2023 | Hemoblast Bellows |
| Covidien LP | $16.30 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.78 | 2022 | |
| Siemens Medical Solutions USA, INC. | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.